Advanced Solid Tumors With Alterations of FGFR1, 2 and/or 3
Also known as: Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11886 | Infigratinib | 1 | Completed | 1 |